TH9619 clinical trials

Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors

This study is testing a new medicine, TH9619, for people with advanced cancers like bowel, head and neck, lung, and stomach cancer. It's the first time TH9619 is being given to people, and doctors want to find the safest and most effective dose.